CI Investments Inc
NVCR icon

CI Investments Inc’s NovoCure NVCR Stock Holding History

CI Investments Inc’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-797
Closed -$13K – 1314
2023
Q3 		$13K Sell
797
-2,020
-72% -$58.2K ﹤0.01% 1146
2023
Q2 		$117K Buy
2,817
+1,904
+209% +$118K ﹤0.01% 748
2023
Q1 		$55K Buy
913
+758
+489% +$60.6K ﹤0.01% 877
2022
Q4 		$11K Buy
155
+20
+15% +$1.5K ﹤0.01% 1123
2022
Q3 		$10K Sell
135
-3
-2% -$234 ﹤0.01% 1129
2022
Q2 		$10K Sell
138
-316
-70% -$23.8K ﹤0.01% 1040
2022
Q1 		$38K Sell
454
-26
-5% -$1.92K ﹤0.01% 1000
2021
Q4 		$36K Buy
480
+91
+23% +$9.13K ﹤0.01% 1046
2021
Q3 		$45K Buy
+389
New +$58.8K ﹤0.01% 982

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CI Investments Inc's NVCR Position: Q4 2023 in Review

CI Investments Inc sold out of NovoCure (NVCR) in Q4 2023, closing a stake of 797 shares — an estimated $13K sold.

CI Investments Inc first reported a position in NVCR in Q3 2021 and held it in 9 quarters. The position peaked at $117K in Q2 2023. 219 funds tracked by Wall St. Rank hold NVCR as of Q4 2023.

  • CI Investments Inc reported no remaining NovoCure position as of Q4 2023 after selling out during the quarter.
  • CI Investments Inc sold 797 NovoCure shares in Q4 2023, an estimated $13K.
  • CI Investments Inc first reported a position in NovoCure in Q3 2021 and held it in 9 quarters.
  • CI Investments Inc's NovoCure position peaked at $117K in Q2 2023.
  • 219 funds tracked by Wall St. Rank held NovoCure as of Q4 2023.

Based on CI Investments Inc's 13F filing for Q4 2023, filed 12 Feb 2024.